Vyome Holdings Inc (HIND)

Currency in USD
3.630
-0.250(-6.44%)
Closed·
4.200+0.570(+15.70%)
·
Unusual Post-Market activity
HIND is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.6303.800
52 wk Range
3.570519.000
Key Statistics
Prev. Close
3.88
Open
3.8
Day's Range
3.63-3.8
52 wk Range
3.57-519
Volume
23.91K
Average Volume (3m)
78.36K
1-Year Change
-99.15%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HIND Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Vyome Holdings Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Vyome Holdings Company Profile

As of August 14, 2025, ReShape Lifesciences Inc. was acquired by Vyome Therapeutics Inc., in a reverse merger transaction. ReShape Lifesciences Inc. provides products and services that manage and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company’s product portfolio includes Lap-Band System to treat obesity and invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band to optimize an individual’s comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus. It is involved in the development of the ReShape Obalon Balloon System, which consists of a swallowable capsule that tracks and displays the location of the balloon during placement; and the Diabetes Bloc-Stim Neuromodulation (DBSN) device, a technology that is in development for the treatment of type 2 diabetes mellitus. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in Irvine, California.

Vyome Holdings Inc Earnings Call Summary for Q3/2025

  • Vyome Holdings reported a Q3 2025 net loss of $9.2 million due to merger-related charges, with stock declining 4.56% to $4.40 in premarket trading.
  • The company extended its cash runway through 2026 despite financial challenges, reporting $5.7 million in cash and equivalents with 5,556,295 outstanding shares.
  • Positive interim Phase 2 results for lead program VT1953 were announced, with FDA interactions planned for H1 2026 as part of pipeline development.
  • Leadership was strengthened with a new CTO and Senior VP of Clinical Development, while the company completed its NASDAQ listing with 100% common stock structure.
  • Vyome is pursuing an AI-focused healthcare initiative through acquisitions, leveraging its strategic position bridging U.S. and India innovation corridors.
Last Updated: 20/11/2025, 15:52
Read Full Transcript

Compare HIND to Peers and Sector

Metrics to compare
HIND
Peers
Sector
Relationship
P/E Ratio
0.0x0.0x−0.6x
PEG Ratio
0.000.000.00
Price/Book
0.0x0.0x2.6x
Price / LTM Sales
0.0x0.0x3.2x
Upside (Analyst Target)
0.0%0.0%41.8%
Fair Value Upside
Unlock0.0%5.1%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Aug 14, 2025
EPS / Forecast
-9.00 / --
Revenue / Forecast
1.24M / --
EPS Revisions
Last 90 days

People Also Watch

2.200
FRGT
-9.84%
1.4600
INHD
-7.59%
0.4000
HUBC
-5.57%
1.2250
AVX
+4.70%
3.670
QNCX
+0.55%

FAQ

What Is the Vyome Holdings (HIND) Share Price Today?

The live Vyome Holdings share price today is 3.630

What Stock Exchange Does Vyome Holdings (HIND) Trade On?

Vyome Holdings is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Vyome Holdings?

The stock symbol (also called a 'ticker') for Vyome Holdings is "HIND."

What Is the Current Vyome Holdings Market Cap?

As of today, Vyome Holdings market capitalisation is 2.50M.

What Is Vyome Holdings's (HIND) Earnings Per Share (TTM)?

The Vyome Holdings EPS is currently -55.30 (Trailing Twelve Months).

Is HIND a Buy or Sell From a Technical Analyst Perspective?

Based on today's Vyome Holdings moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Vyome Holdings Stock Split?

Vyome Holdings has split 11 times. (See the HIND stock split history page for full effective split date and price information.)

How Many Employees Does Vyome Holdings Have?

Vyome Holdings has 18 employees.

What is the current trading status of Vyome Holdings (HIND)?

As of 24 Dec 2025, Vyome Holdings (HIND) is trading at a price of 3.630, with a previous close of 3.880. The stock has fluctuated within a day range of 3.630 to 3.800, while its 52-week range spans from 3.570 to 519.000.

What Is the HIND After Hours Price?

HIND's last after hours stock price is 4.200, the stock has decreased by 0.570, or 15.700%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.